Massivemarkets

Nasdaq: KLRA · Listed Apr 17, 2026

Kailera Therapeutics IPO

IPO price

$16.00

Kailera Therapeutics (KLRA) priced its IPO at $16.00 a share and has traded on Nasdaq since Apr 17, 2026.

KLRA today$11.62-27.38%since IPO15-min delayed · as of 7:30:03 PM EST on Nov 18, 2026

See the KLRA quote

First trading day · Apr 17, 2026

IPO price 16.00VWAP 25.63first trade 26.00+62.50% from the IPO pricehigh 26.80$26.16volume · rising bars above the line, falling bars below460.27K1:254:00
IPO price
$16.00
the top of the range of $14 to $16
First trade
$26.00
+62.50% from the IPO price
First-day last trade
$26.16
+63.47% from the IPO price, regular session
Raise
$625M
before the underwriters' option

These numbers are from the first trading day, Apr 17, 2026.

How KLRA did against the market

KLRA against the market, from its first trade at 1:25 ET to the last trade of the session.

KLRA from its first trade
+0.60%
Against the market (QQQ)
+0.3 pts

KLRA rose 0.6% from its first trade to the last trade of the session. That is 0.3 points better than the market.

Same-day moves do not show that KLRA caused them. The market is QQQ, the Nasdaq-100 ETF.

The debut race

KLRA against other big listings, as the percent change from each stock's own IPO price.

The first 30 trading days. Each point is the last regular-session trade of a day.

+50%+100%+150%+200%+250%IPOday 1day 5day 10day 15day 20day 25day 30Figma '25 +69.64%Reddit '24 +40.32%CoreWeave '25 +28.42%Arm '23 -3.06%Klarna '25 -7.33%KLRA +43.50%

The IPO scoreboard

KLRA against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

KLRA against other big IPOs: the money raised, and the return from each IPO price at the first trade, at the last trade of day 1, and on day 5 and day 30.
IPORaisedFirst tradeDay 1 closeDay 1 close, as a barDay 5Day 30
Kailera Therapeutics '26$625M+62.50%+63.47%+56.94%+43.50%
Figma '25$1.22B+157.58%+252.42%+173.64%+69.64%
Circle '25$1.05B+122.58%+168.45%+278.18%+622.98%
Reddit '24$748M+38.24%+47.97%+69.90%+40.32%
Arm '23$5.23B+10.00%+23.76%+3.63%-3.06%
Klarna '25$1.37B+30.00%+16.14%+13.73%-7.33%
CoreWeave '25$1.5B-2.50%+0.02%+34.32%+28.42%

Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.

The offering

The Kailera Therapeutics IPO offers 39.06M shares to raise $625M, before any underwriters' option.

$12$14$15$16$18
Expected price range
$14 to $16
IPO price
$16.00
Shares offered
39.06M
Money raised
$625M
Listing date
Apr 17, 2026
Exchange
Nasdaq
Security
Ordinary Shares

Money raised, against the largest IPOs

  • Alibaba '14$21.77B
  • Facebook '12$18.41B
  • Rivian '21$11.93B
  • Uber '19$8.1B
  • Arm '23$5.23B
  • Kailera Therapeutics$625M

Where KLRA ranks

Kailera Therapeutics's market cap against the largest US-listed companies.

Market cap, against the largest US-listed companies

  • AAPL$5.12T
  • MSFT$3.77T
  • NVDA$3.65T
  • GOOGL$3.47T
  • AMZN$2.9T
  • TSM$1.88T
  • AVGO$1.69T
  • META$1.58T
  • TSLA$1.52T
  • BRK.B$1.22T
  • KLRA$1.53B

KLRA news

The latest news and headlines about Kailera Therapeutics (KLRA).

Filings and the company

What Kailera Therapeutics has disclosed to the SEC, and the basic facts about the listing.

8-K filings

Material events that Kailera Therapeutics discloses to the SEC on Form 8-K.

  • On November 4, 2026, Kailera Therapeutics, Inc. (the "Company") issued a press release reporting its financial results for the quarter ended September 30, 2026.

  • Bylaw amendmentApr 20, 2026

    On April 20, 2026, in connection with the closing of the IPO, the amended and restated bylaws of the Company became effective. The Amended and Restated Bylaws amended and restated the Company's prior bylaws in their entirety to, among other things: (i) establish procedures relating to the presentation of stockholder proposals at stockholder meetings; (ii) establish procedures relating to the nomination of directors; and (iii) conform to the amended provisions of the Restated Certificate.

About Kailera Therapeutics

Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.

Ticker
KLRA
Exchange
Nasdaq
Market
stocks
Type
CS
Currency
USD
Industry
PHARMACEUTICAL PREPARATIONS
Listed
Apr 17, 2026
Security
Ordinary Shares
Company website

Frequently asked questions

What was the Kailera Therapeutics IPO price?

$16.00 a share.

When did Kailera Therapeutics go public?

Kailera Therapeutics listed on Nasdaq on Apr 17, 2026 under the ticker KLRA.

How much did the Kailera Therapeutics IPO raise?

$625M, before any underwriters' option.

How did Kailera Therapeutics open on its first day?

KLRA first traded at $26.00, +62.50% from the IPO price of $16.00.

How did KLRA close on its first day?

Its last regular-session trade was $26.16, +63.47% from the IPO price of $16.00.

What was the KLRA first-day trading range?

$23.70 to $27.50 in the regular session.

How many KLRA shares traded on the first day?

7.84M shares in the regular session.

How many shares did Kailera Therapeutics sell in its IPO?

39.06M shares.

How did KLRA do against the market on its first day?

KLRA rose 0.6% from its first trade to the last trade of the session. That is 0.3 points better than the market (QQQ, the Nasdaq-100 ETF).

What exchange is KLRA listed on?

Kailera Therapeutics lists on Nasdaq under the ticker KLRA.

Build with Massive

Get the KLRA data behind this page

The Massive endpoint behind each section of this page
What the page showsEndpoint
Offering terms and dates/vX/reference/ipos
Price/v3/snapshot
Chart, VWAP, and the market comparison/v2/aggs/ticker/KLRA/range/5/minute
Market cap/v3/reference/tickers/KLRA
News/v2/reference/news
Filings/vX/disclosures

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.